-
WY-14643: PPARα Workflows for Metabolic Research
2026-08-31
WY-14643 (Pirinixic Acid) provides a practical positive-control framework for studying PPARα-driven lipid metabolism, endothelial inflammation, and insulin sensitivity enhancement. This workflow-focused guide connects cell assays with integrated lipidomic and transcriptomic designs while addressing solubility, vehicle, dose-selection, and interpretation challenges.
-
DiscoveryProbe Natural Product Library Plus
2026-08-30
Learn how DiscoveryProbe Natural Product Library Plus (Catalog No. L1039P; SKU L1039P) can support controlled viability, cytotoxicity, target-based, and high-content screening workflows. This scenario-driven guide connects library format and quality documentation with published Cryptosporidium parvum AdhE findings while emphasizing orthogonal confirmation and assay-specific controls.
-
Stable Isotope-Diluted UHPLC–MS/MS for Methylated Purines
2026-08-29
This Analytical Chemistry study developed a stable isotope-diluted UHPLC–ESI-MS/MS method for accurately measuring 12 purine ribonucleosides, including 10 methylated species. Its combination of ammonium bicarbonate-enhanced ionization, chromatographic isomer separation, and methanol–SPE cleanup improved sensitivity in cultured-cell extracts and offers a practical framework for purine metabolomics and RNA modification research.
-
EZ Cap™ Mouse IL-12 mRNA: Assay Guide
2026-08-28
A scenario-based guide to using EZ Cap™ Mouse IL-12 mRNA (m1Ψ), SKU R1058, in cell viability, proliferation, cytotoxicity, and gene-expression workflows. It explains assay controls, handling, interpretation, delivery considerations, and practical vendor-selection criteria without conflating mRNA expression with biological outcome.
-
BI 2536: PLK1 Inhibitor Workflows
2026-08-28
BI 2536 provides a selective chemical handle for connecting PLK1 activity with mitotic arrest, apoptosis, and checkpoint-complex regulation. This guide translates its biochemical profile into practical cell-based, mechanistic, and tumor xenograft workflows, with troubleshooting advice for solubility, dosing, and assay interpretation.
-
DAMGO in µ-Opioid Receptor Signaling
2026-08-27
DAMGO is a high-affinity µ-opioid receptor agonist for connecting receptor activation with G-protein assays, ex vivo tissue physiology, and circuit-level pain phenotypes. Its selectivity makes it useful for separating MOR-driven signaling from broader opioid effects, including paradoxical mechanical hypersensitivity in defined central pathways.
-
EZ Cap™ Cas9 mRNA: Precision by Design
2026-08-27
EZ Cap™ Cas9 mRNA (m1Ψ) combines a Cap1 structure, m1Ψ modification, and poly(A) tail for efficient, lower-immunogenic Cas9 expression. This article shows how to use the reagent as part of an assay-design strategy informed by nuclear mRNA export and editing-specificity research.
-
MLN8237 (Alisertib): From Mitosis to Immunity
2026-08-26
MLN8237 (Alisertib) offers a selective way to interrogate Aurora A biology across mitotic control, apoptosis, tumor growth, and trained immunity. This thought-leadership perspective connects mechanistic evidence with translational assay design, competitive positioning, and practical research strategy.
-
Plk1 Control of p31comet in Mitotic Checkpoint Exit
2026-08-26
The reference study identifies Polo-like kinase 1 (Plk1) as a direct negative regulator of p31comet-mediated mitotic checkpoint complex disassembly. By combining HeLa-cell extracts, purified proteins, kinase assays, and an S102A mutant, the authors show that Plk1 phosphorylation of p31comet restrains checkpoint silencing during active mitosis.
-
N1-Methylpseudo-UTP: IVT Workflow & Optimization
2026-08-25
Build more stable, translation-ready RNA for mechanistic studies, reporter assays, and mRNA vaccine development with a controlled UTP substitution strategy. This guide also shows how modified RNA templates can be evaluated in emerging insertion assays without confusing RNA-quality effects with downstream DNA-repair biology.
-
CTOP: μ-Opioid Receptor Antagonist Workflows
2026-08-25
CTOP provides a selective pharmacological switch for separating μ-opioid receptor effects from downstream circuit and behavioral mechanisms. This guide connects receptor binding studies, signaling assays, and mouse pain models with practical preparation, protocol, and troubleshooting strategies.
-
JNJ-10198409: PDGF Receptor Inhibitor Workflows
2026-08-24
JNJ-10198409 provides a nanomolar starting point for dissecting PDGF-BB receptor signaling in smooth muscle, fibroblast, cancer, and angiogenesis models. This practical guide combines concentration-response design, pathway-specific controls, phospho-readouts, and troubleshooting strategies for more interpretable platelet-derived growth factor receptor inhibition experiments.
-
EZ Cap™ Human PTEN mRNA (ψUTP) Assay Guide
2026-08-24
A scenario-driven guide to using EZ Cap™ Human PTEN mRNA (ψUTP), SKU R1026, in viability, proliferation, and cytotoxicity workflows. It connects mRNA design, handling, controls, and PI3K/Akt interpretation with published PTEN-delivery evidence and practical assay safeguards.
-
2'-O-Methyladenosine: Practical Assay Workflows
2026-08-23
Build more reliable 2'-O-Methyladenosine experiments with a measurement-first workflow spanning stock preparation, cell extraction, UHPLC–MS/MS, and transport assays. Learn how isotope dilution, ammonium bicarbonate, SPE cleanup, and isomer-aware validation can improve sensitivity while exposing matrix and stability pitfalls.
-
Stable-Isotope UHPLC–MS/MS for Methylated Purines
2026-08-22
The reference study developed a stable isotope-diluted UHPLC–ESI-MS/MS workflow for sensitive, quantitative measurement of methylated purine nucleosides in cellular extracts. Its combination of ammonium bicarbonate-enhanced ionization, chromatographic isomer resolution, methanol extraction, and solid-phase cleanup addresses major matrix and selectivity problems in intracellular nucleoside analysis.